From Brain Wearables to Rehab Robotics: Two Indian Startups Raise Fresh Capital

India’s healthcare innovation ecosystem is entering a decisive phase—where brain tech and rehabilitation robotics are no longer futuristic ideas but fast-scaling realities. Two startups, Mave Health and Rymo Technologies, have just raised fresh capital to tackle one of the most complex challenges in modern healthcare: neurological health.

From improving focus and mental resilience to accelerating recovery after strokes, these startups are betting big on technology-led care—and investors are clearly backing the vision.

Mave Health Raises $2.1 Million to Scale Neurotech Wearables Globally

Neurotechnology startup Mave Health has secured $2.1 million (₹18 crore) in a seed funding round led by Blume Ventures, with participation from Inuka Capital, Stanford Angels, founders of Groww, Raymond Russell, Aureolis Ventures, Juhi Bhatnagar, and All In Capital.

This comes shortly after its $750K pre-seed round in November 2023, signaling strong investor confidence in the company’s rapid execution.

What Mave Health Is Building

Founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, Mave Health is focused on non-invasive brain stimulation technology designed for everyday use.

Its flagship product is a lightweight wearable headset (~100g) that uses transcranial direct current stimulation (tDCS) to target the prefrontal cortex—an area linked to focus, mood, and stress regulation.

The idea is simple but powerful:
👉 20 minutes a day to rewire how your brain handles productivity and emotional balance.

Read more: Amazon Cuts 16,000 Jobs as CEO Bets Big on AI and $600B AWS Future

Why It Matters

Mental performance tools have largely been limited to apps and therapy. Mave is pushing the boundary by bringing hardware into the equation, offering:

• Daily brain stimulation sessions integrated into routines

• A companion app for tracking progress and personalization

• No brain data collection—addressing rising privacy concerns

Early user data is striking:

• 80% reported productivity gains above 60%

• 75% saw stress reduction exceeding 50%

• Average mood improvement reached 77%

Traction & Market Momentum

Mave Health isn’t just another lab-stage startup—it’s already showing strong consumer demand:

• Three product batches sold out within 36 hours

• Over 1 million impressions on launch campaigns

• Interest from global athletes like UFC fighter Max Griffin

• 500+ beta users before public release

The company is now gearing up for commercial shipments in April 2026 across the US and India, while scaling manufacturing with the new funds.

Editorial Insight

Here’s the bigger shift:
Mave Health is part of a new wave where brain optimization is becoming consumerized—moving from clinics to living rooms.

If execution matches ambition, this could be the “wearables moment” for cognitive health, much like what fitness bands did for physical wellness.

Rymo Technologies Raises ₹10 Crore to Transform Neuro-Rehabilitation with Robotics

Mumbai-based Rymo Technologies has raised ₹10 crore in seed funding, led by IAN Group through its evergreen fund, along with participation from angel investors.

The capital will fuel product innovation, manufacturing expansion, and international growth, targeting markets across ASEAN and the Middle East.

Solving a Massive Healthcare Gap

Founded in 2020 by Chirag Shah and Abhishek Rai, Rymo Technologies is tackling a critical but underserved problem:
👉 Access to effective neuro-rehabilitation.

With rising cases of strokes and neurological disorders, the demand for rehab is exploding—but supply isn’t keeping up due to:

• Shortage of trained therapists

• High costs of robotic rehabilitation systems

• Limited accessibility outside top hospitals

The Technology Edge

Rymo’s approach blends robotics, AI, and virtual reality into a unified rehabilitation platform.

Its flagship solution, Mobi-L, is a multi-joint robotic system designed to help patients regain mobility through:

• AI-driven therapy personalization

• Data-backed recovery tracking

• Modular and scalable hardware design

The company has built a strong tech foundation with patented hardware architecture and proprietary algorithms trained on patient data.

Real-World Impact

Unlike many early-stage startups, Rymo already demonstrates clinical traction:

• 452+ device installations

• 354 clinical partners, including AIIMS, Apollo Hospitals, and Manipal Hospitals

• 7,500+ patients treated

• 15,000+ therapy hours delivered

• Up to 25% faster recovery outcomes reported

Editorial Insight

Rymo’s story highlights a different but equally important shift:
Healthcare is moving from manual, therapist-heavy models to scalable, tech-driven systems.

In a country like India—where healthcare access is uneven—this isn’t just innovation. It’s infrastructure building.

The Bigger Picture: Neurotech Is Becoming the Next Healthcare Frontier

Both Mave Health and Rymo Technologies are operating in different segments—cognitive enhancement vs rehabilitation—but the underlying thesis is the same:

👉 The brain is the next battleground for healthcare innovation.

Investors are no longer just funding hospitals or diagnostics—they’re backing deep-tech solutions that can scale globally and deliver measurable outcomes.

What This Signals

• Consumer healthcare is becoming proactive, not reactive

• Robotics and AI are redefining therapy and recovery

• India is emerging as a serious player in neurotech innovation

Final Take

This isn’t just about two funding rounds.

It’s about a shift in how we think about brain health—from treatment to optimization, from clinics to daily life.

And if these startups succeed, the future of healthcare won’t just be about living longer.

It will be about thinking better, recovering faster, and functioning at your peak.